Tumors collected at the end of the experiments showed that M1-21 significantly decreased the size and weight of engrafted tumors compared to controls (Fig. 3G), correlated with the decreased levels of FOXM1 and FOXM1-regulated CDC25B and PLK1 in M1-21-treated tumor samples (Fig. S12B). This evidence concerns the gene CDC25B and neoplasm.